Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TGF‐β1 mediates pathologic changes of secondary lymphedema by promoting fibrosis and inflammation
Jung Eun Baik, Hyeung Ju Park, Raghu P. Kataru, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 6
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

The Role of Inflammation in Lymphedema: A Narrative Review of Pathogenesis and Opportunities for Therapeutic Intervention
Catharine Bowman, Stanley G. Rockson
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3907-3907
Open Access | Times Cited: 16
The Future of Lymphedema: Potential Therapeutic Targets for Treatment
Stav Brown, Adana C. Campbell, Kevin Kuonqui, et al.
Current Breast Cancer Reports (2023) Vol. 15, Iss. 3, pp. 233-241
Open Access | Times Cited: 17
Current Status of Lymphangiogenesis: Molecular Mechanism, Immune Tolerance, and Application Prospect
Hongyang Deng, Jiaxing Zhang, Fahong Wu, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1169-1169
Open Access | Times Cited: 13
Apelin-VEGF-C mRNA delivery as therapeutic for the treatment of secondary lymphedema
Justine Creff, Asalaa Lamaa, Emeline Benuzzi, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 2, pp. 386-415
Open Access | Times Cited: 4
Liver Lymphatic Dysfunction as a Driver of Fibrosis and Cirrhosis Progression
Jain Jeong, Shao‐Jung Hsu, Daiki Horikami, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
The microenvironment of secondary lymphedema. The key to finding effective treatments?
Lazina Hossain, Karina Pereira Gomes, Samaneh Safarpour, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167677-167677
Open Access
The prognostic effect and mechanism of erysipelas in cancer-associated lymphedema
Peilin Li, Zimin Zhao, Yuguang Sun, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Single-nuclear transcriptomics of lymphedema-associated adipose reveals a pro-lymphangiogenic stromal cell population
Gregory P. Westcott, Margo P. Emont, Anton Gulko, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Targeting uPARAP Modifies Lymphatic Vessel Architecture and Attenuates Lymphedema
Fabrice Gucciardo, Alizée Lebeau, Sébastien Pirson, et al.
Circulation (2025)
Closed Access
The Erk1/2-EGR1 signaling pathway is involved in lipopolysaccharide-induced transforming growth factor-beta 1 expression in mouse macrophages
Weimin Zhao, Wang Hong, Chaohui Dai, et al.
Microbial Pathogenesis (2025), pp. 107453-107453
Closed Access
Gata3 Insufficiency Accelerates Recanalization of Damaged Lymphatics via Adjusting Collagen Composition
Moyuru Hayashi, Takuya Harada, Jun Takai, et al.
Lymphatics (2025) Vol. 3, Iss. 1, pp. 7-7
Open Access
Topical captopril: a promising treatment for secondary lymphedema
Stav Brown, Gabriela D. García Nores, Ananta Sarker, et al.
Translational research (2023) Vol. 257, pp. 43-53
Open Access | Times Cited: 10
Metformin eliminates lymphedema in mice by alleviating inflammation and fibrosis: implications for human therapy
Miaomiao Wei, Liangliang Wang, Xin Liu, et al.
Plastic & Reconstructive Surgery (2024) Vol. 154, Iss. 6, pp. 1128e-1137e
Open Access | Times Cited: 3
Molecular pathophysiology of secondary lymphedema
Sang‐Oh Lee, Il‐Kug Kim
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
Treatment with YIGSR peptide ameliorates mouse tail lymphedema by 67 kDa laminin receptor (67LR)-dependent cell-cell adhesion
Yuta Sakae, H. Takada, Shizuko Ichinose, et al.
Biochemistry and Biophysics Reports (2023) Vol. 35, pp. 101514-101514
Open Access | Times Cited: 6
Targeting lymphatic function in cardiovascular-kidney-metabolic syndrome: preclinical methods to analyze lymphatic function and therapeutic opportunities
Joseph Wayne M. Fowler, LouJin Song, Kelly Tam, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 2
The combination of paeoniflorin and metformin synergistically inhibits the progression of liver fibrosis in mice
Lingjie Meng, Huijing Lv, Qinghong Kong, et al.
European Journal of Pharmacology (2024) Vol. 981, pp. 176917-176917
Closed Access | Times Cited: 2
The role of vascular and lymphatic networks in bone and joint homeostasis and pathology
Jingxiong Huang, Chengcheng Liao, Jian Yang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
Ultrasound-Mediated Piezoelectric Microneedles Regulating Macrophage Polarization and Remodeling Pathological Microenvironment for Lymphedema Improvement
Xueqian Wang, Chengyao Han, Jingyi Xia, et al.
ACS Nano (2024) Vol. 19, Iss. 1, pp. 1447-1462
Closed Access | Times Cited: 2
Surgical lymphedema models in the mice hindlimb—A systematic review and quality assessment
Amar Bučan, Martin Frendø, Mikaella Ty Ngo, et al.
Microsurgery (2023) Vol. 44, Iss. 1
Open Access | Times Cited: 5
Breast cancer-related lymphedema results in impaired epidermal differentiation and tight junction dysfunction
Adana-Christine Campbell, Jung Eun Baik, Ananta Sarker, et al.
Journal of Investigative Dermatology (2024)
Closed Access | Times Cited: 1
Crosstalk of ubiquitin system and non-coding RNA in fibrosis
Huamin Zhang, Yutong Zhou, Canhua Jiang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 10, pp. 3802-3822
Open Access | Times Cited: 1
Decoding tumor-fibrosis interplay: mechanisms, impact on progression, and innovative therapeutic strategies
Huiguang Chen, Xuexin Xu, Jingxian Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Fibronectin-1 is a dominant mechanism for rheumatoid arthritis via the mediation of synovial fibroblasts activity
Jie Yang, Yan Zhang, Jingqi Liang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top